May 07, 2019 / 08:30PM GMT
Operator
Good afternoon, and welcome to the Iovance Biotherapeutics First Quarter 2019 Financial Results Conference Call. (Operator Instructions) Please be advised that the call is being recorded at the company's request.
Now I would like to turn the conference over to Tim Morris, Chief Financial Officer of -- at Iovance. Sir, please go ahead.
Timothy E. Morris - Iovance Biotherapeutics, Inc. - CFO, Principal Accounting Officer, Corporate Secretary & Treasurer
Thank you, Angela. Good afternoon, everyone, and thank you for joining us today. With me on the call is Kelly DiTrapani, Vice President of Medical Affairs; and Michael Swartzburg, Vice President of Finance. We'd like to note that Maria Fardis, our Executive Officer, is unfortunately unavailable to participate in today's call due to a last-minute trip involving the health of a relative, and we are extending our well wishes to her and her family at this time. This afternoon, we issued a press release that you can find on our website at iovance.com, which includes financial results for the first quarter
Q1 2019 Iovance Biotherapeutics Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
